Log In
BCIQ
Print this Print this
 

CER-209

  Manage Alerts
Collapse Summary General Information
Company Cerenis Therapeutics S.A.
DescriptionPurinergic receptor P2Y G protein-coupled 13 (P2RY13; P2Y13) agonist
Molecular Target Purinergic receptor P2Y G protein-coupled 13 (P2RY13) (P2Y13)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today